Sotera Health (NASDAQ:SHC) Shares Sold by Warburg Pincus LLC

Warburg Pincus LLC lowered its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 16.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 73,822,952 shares of the company's stock after selling 15,000,000 shares during the quarter. Sotera Health makes up approximately 63.2% of Warburg Pincus LLC's holdings, making the stock its biggest holding. Warburg Pincus LLC owned about 26.06% of Sotera Health worth $1,232,843,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp raised its position in shares of Sotera Health by 18.5% during the third quarter. State Street Corp now owns 4,126,806 shares of the company's stock worth $68,918,000 after acquiring an additional 644,236 shares during the last quarter. Quantinno Capital Management LP increased its position in Sotera Health by 59.4% in the third quarter. Quantinno Capital Management LP now owns 29,217 shares of the company's stock worth $488,000 after purchasing an additional 10,885 shares during the period. Maven Securities LTD acquired a new stake in Sotera Health in the third quarter worth about $1,670,000. True Wealth Design LLC bought a new stake in Sotera Health during the 3rd quarter worth about $32,000. Finally, Maverick Capital Ltd. lifted its position in Sotera Health by 3.5% during the 3rd quarter. Maverick Capital Ltd. now owns 3,497,367 shares of the company's stock valued at $58,406,000 after purchasing an additional 118,353 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on SHC shares. The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday. They issued a "neutral" rating and a $14.00 price target on the stock. Royal Bank of Canada restated an "outperform" rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Finally, Citigroup boosted their target price on Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $16.08.

Sotera Health Stock Up 1.2 %

Shares of SHC stock traded up $0.16 during trading on Friday, reaching $13.13. The company's stock had a trading volume of 988,391 shares, compared to its average volume of 1,712,090. Sotera Health has a one year low of $10.71 and a one year high of $17.44. The business has a fifty day moving average price of $14.96 and a 200-day moving average price of $14.06. The company has a market cap of $3.72 billion, a price-to-earnings ratio of 52.52 and a beta of 1.96. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business's revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.18 EPS. Analysts anticipate that Sotera Health will post 0.61 earnings per share for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.